A
Last Price
52 Week Range
$13.62 - $13.62
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | - |
EV | - |
Shares Outstanding | 25.00K |
Beta | - |
Industry | Biotechnology |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
AgomAb Therapeutics NV
AGMB
Sector
Healthcare
Industry
Biotechnology
CEO
Knotnerus, Tim
Employees
Website
agomab.comIPO Date
2024-05-29
Headquarters
Posthoflei 1/6, Antwerp, Antwerp, 2600 Belgium
The last closing price of AgomAb Therapeutics NV (AGMB) is $10.47, reflecting a -5.16% change from the prior session. Last updated: May 15, 2026 at 3:03 PM Eastern Time
Over the last year, AgomAb Therapeutics NV (AGMB) has established a 52-week price range between a high of $13.62 and a low of $13.62. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 7:02 PM Eastern Time
AgomAb Therapeutics NV (AGMB) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, AgomAb Therapeutics NV (AGMB) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: May 15, 2026 at 3:03 PM Eastern Time
Like other publicly traded stocks, AgomAb Therapeutics NV (AGMB) shares are bought and sold on stock exchanges such as Nasdaq and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for AgomAb Therapeutics NV (AGMB) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add AGMB to your watchlist.
AgomAb Therapeutics NV trades under the ticker symbol AGMB on the Nasdaq stock exchange. The ticker AGMB is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers